Moderna Creates Marlborough Biomanufacturing Center
Moderna is investing $322 million to create a state-of-the-art biomanufacturing center in Marlborough, Mass. Offering leading-edge environments for the production of innovative therapies and vaccines, the state-of-the-art facility will also include a cleanroom, labs, offices, and warehouse areas. The project involves the renovation of a two-story, 140,000-sf building that was purchased in spring of 2023 from Oxford Properties. Sited on 24 acres, the existing structure will be expanded to provide an additional 60,000 sf of space.